In particular, the highest frequency of KRAS alterations is identified in pancreatic adenocarcinoma (88%), colon and rectal adenocarcinoma (50%), and in lung adenocarcinoma (32%) (4, 5). The gene discussed is KRAS; the disease is lung adenocarcinoma.